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Abstract Apoptosis was induced in THP.I cells, a human mon- 
ocytic tumour cell line, by diverse stimuli including cyclo- 
heximide, thapsigargin, etoposide and staurosporine. Induction of 
apoptosis by all these stimuli, except etoposide, was enhanced in 
the presence of the trypsin-like protease inhibitor, Na-tosyl-L- 
lysinyl chloromethyl ketone (TLCK). Induction of apoptosis, as- 
sessed by morphological, flow cytometric and biochemical crite- 
ria, including proteolysis of poly(ADP-ribose) polymerase and 
cleavage of DNA to large kilobasepair fragments, was completely 
abrogated when cells were pretreated with an ICE-like 
protease inhibitor, Z-Val-Ala-Asp'fluoromethylketone. This sug- 
gested that an ICE homologue was a common mediator of apop- 
tosis in THP.I cells. 
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I. Introduction 
Apoptosis is a major form of cell death important in verte- 
brate development, tissue homeostasis and in many diseases 
[1,2]. It is recognized by distinct morphological changes, includ- 
ing cell shrinkage, nuclear condensation and fragmentation [3]. 
It has been proposed that all cells except blastomeres would die 
by apoptosis in the absence of survival signals [4]. The ability 
of cells to undergo apoptosis can be induced by diverse stimuli 
including chemicals, radiation and viruses [3,5]. These diverse 
stimuli trigger a range of different signalling events, including 
elevations in cytosolic Ca 2÷, cAMP accumulation, alterations 
in protein kinase C and tyrosine kinase activities, oxidative 
stress, generation ofceramide or nitric oxide [6]. These different 
signals ellicit a common response by apparently converging on 
a single pathway(s) characterised by common biochemical nd 
morphological changes of apoptosis [3,5]. 
Some features of the cell death program appear highly con- 
served from worm to man. During development, 131 cells of the 
nematode, Caenorhabditis elegans, die and display an apoptotic 
morphology [1,7]. Two genes ced-3 and ced-4 are required for 
these cells to die. Little is known of ced-4 but eed-3 encodes a
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protein, which has sequence homology to the mammalian cys- 
teine protease, interleukin-lfl converting enzyme (ICE) [8]. Re- 
cent studies have identified a family of ced-3 related genes 
including ich-lt, nedd-2 and CPP32, whose overexpression i - 
duces cell death by apoptosis [8 12]. The C.elegans gene, ced-9, 
suppresses cell death induced by ced-3 and ced-4 and encodes 
a protein homologous to the mammalian protein Bcl-2 [13]. 
Biochemically, the characteristic most commonly associated 
with apoptosis is internucleosomal cleavage of DNA recog- 
nized as a DNA ladder on conventional garose gel electropho- 
resis [14]. It appears that DNA is initially cleaved into large 
kilobase-pair fragments (200-300 and 30-50 kbp in length) 
[15,16] and it is from these that the DNA ladders are derived 
[16-18]. Increasing attention is now being paid to the role of 
proteolysis in apoptosis. In addition to a ced-3/ICE related 
protease, a possible role(s) for other proteases has been impli- 
cated in a number of different biological systems [19-21]. In a 
recent study, TLCK inhibited apoptosis induced by diverse 
stimuli suggesting a trypsin-like protease is a common effector 
of thymocyte apoptosis [22]. 
During the early stages of apoptosis a number of proteins 
including histones, lamins, DNA topoisomerase I and II, 
poly(ADP ribose)-polymerase (PARP) and U1 small ribonucle- 
oprotein are degraded [19,23]. Although the proteolytic leav- 
age of PARP has been proposed as an early biochemical 
marker of apoptosis [24], we do not as yet know the biologically 
relevant substrate(s) of any protease involved in apoptosis. 
Much interest has focussed on ICE due to its structural similar- 
ity to ced-3 [8]. ICE, identified and isolated from human mon- 
ocytic THE 1 cells, cleaves prolL-lf l  between Asp ~ 16 and Ala ~7 
to yield the active 17.5 kDa cytokine [25]. This protease has an 
unusual requirement for aspartic acid in the P1 position, a 
property possessed by only one other known protease, 
granzyme B [26]. In contrast, TLCK inhibits trypsin-like pro- 
teases, which require a basic amino acid in the P1 position [27]. 
Peptide substrates for ICE must also contain at least four 
amino acids in the P1-P4 positions [25]. A critical role in apop- 
tosis for an ICE homologue(s) rather than ICE per se was 
suggested by the finding that thymocytes and macrophages 
from ICE-deficient mice undergo apoptosis normally [28], al- 
though it is not possible to exclude redundancy in the system. 
We have investigated the possible role of ICE or its homo- 
logues in apoptosis in THE 1 cells chosen because they are rich 
in ICE, Ich-1 and other ICE homologues [12]. In order to 
ensure that the biochemical events studied lie on a common 
pathway, apoptosis was induced by mechanistically diverse 
stimuli which act within their own private pathways [5]. Our 
results indicate that in THE1 cells an ICE-like protease is a 
common mediator of apoptosis induced by diverse stimuli act- 
ing by different mechanisms. 
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2. Mater ia l s  and methods 
2.1. Materials 
Media and serum were purchased from Gibco (Paisley, UK). Pronase 
and TLCK were from Boehringer-Mannheim UK (Lewes, UK). 
Z-VAD.FMK was from Enzyme Systems Inc. (Dublin, CA, USA). 
N-Acetyl-tyrosinyl-valinyl-alaninyl-aspartic acid hloromethylketone 
(YVAD.CMK) was obtained from Bachem (Bubendorf, Switzerland). 
N-(N-acetyl-tyrosinyl-valinyl-alaninyl)-3-amino-4-oxobutanoic acid 
(Y-VAD.CHO) was kindly provided by Prof. L. Rubin (Eisai Labora- 
tories, London, UK). All other chemicals were from Sigma Chemical 
Co. (Poole, UK). 
2.2. Cell culture 
THE1 cells were obtained from Dr. K. Whaley, University of Leic- 
ester and were maintained as a suspension culture at 37°C in a 95% 
humidified atmosphere containing 5% CO 2 in RPMI 1640 medium 
(with glutamine), supplemented with 10% FCS, 100 U/ml penicillin, and 
100/~g/ml streptomycin. Cells were split every third day and the density 
was kept at 2.5 5 x 105/ml. Logarithmically growing cultures of THP. 1 
cells were used for all experiments and were seeded at a density of 
0.7 x 106/ml one day prior to the experiment. 
2.3. Field inversion gel eh, ctrophoresis 
Agarose plugs (100/11, containing 0.5 x 106 cells) were prepared for 
field inversion gel electrophoresis as previously described [16]. To detect 
internucleosomal cleavage of DNA using conventional garose gel elec- 
trophoresis, 1 x 106 cells were loaded per lane [29]. 
2.4. Apoptosis assessed by flow cytometry 
We have previously described a flow cytometric method for the 
separation and quantitation ofviable normal and apoptotic thymocytes 
[30]. The basis of this method appears to be the increased permeability 
of the apoptotic ompared to the normal cells [31]. We validated that 
this method with minor modifications, as described, was also suitable 
for the separation and quantitation of normal and apoptotic THE1 
cells. Cells were initially treated with or without apoptosis inducing 
agents and then stained with 1.5/lg/ml Hoechst 33342 for 5 min and 
0.05 ,ug/ml propidium iodide. Analysis was carried out using a Becton 
Dickinson FACS Vantage flow cytometer. After gating out non-viable 
cells (indicated by propidium iodide inclusion), the remaining viable 
cells were displayed as a cytogram of blue fluorescence versus forward 
light scatter. 
2.5. PARP proteolysis 
Cells (0.5 x 106) were prepared for SDS-PAGE as described [32]. 
Proteins were resolved on a 7% SDS-polyacrylamide g l, transferred 
onto nitrocellulose and Western blotting carried out using rabbit anti- 
serum (318) to PARP (diluted 1:8000 in Tris-buffered saline, 0.1% 
Tween 20, pH 7.4). The antibody to PARP was a kind gift from Dr. 
G. Poirier (Quebec, Canada). Detection was achieved with a secondary 
antibody (goat anti-rabbit IgGs) conjugated to horseradish peroxidase 
(diluted 1:2000 in Tris-buffered saline, 0.1% Tween 20, pH 7.4) and an 
ECL detection kit (Amersham Life Science, UK). 
3. Results  
3.1. Z-VAD.FMK inhibits apoptosis induced by diverse stimuli 
Incubat ion of THE1 cells for 4 h with etoposide (25/ IM) ,  
thapsigargin (100 nM), cycloheximide (25 /zM) or stauro- 
sporine (0.5 ¢tM) resulted in the induction of apoptotic cells 
when examined by fluorescence microscopy. In order to obtain 
a quantitat ive assessment of the extent of apoptosis, treated 
cells were stained with Hoechst 33342 and propidium iodide 
and examined by flow cytometry. Two populat ions of viable 
cells, which exhibited either low (R1) or high (R2) blue fluores- 
cence, were observed (Fig. 1). When these cells were sorted, 
those with high blue fluorescence (R2) displayed an apoptotic 
morphology, whereas almost all cells with low blue fluores- 
cence (R1) exhibited a normal morphology (Fig. 1). These re- 
sults confirmed the validity of this flow cytometric method for 
the separation and quant i tat ion of normal and apoptotic 
THE 1 cells. Using this method, it was apparent that apoptosis 
was induced to varying degrees (8-32%) (Table 1) by all the 
stimuli used. 
In thymocytes, TLCK is a potent inhibitor of apoptosis [22]. 
Therefore we investigated the effects of TLCK on apoptosis in 
THE1 cells. TLCK (100/,tM) alone did not induce apoptosis 
(Table 1) or affect cell viability or morphology. TLCK poten- 
tiated apoptosis induced by cycloheximide and thapsigargin but 
inhibited that induced by etoposide (Table 1). Staurosporine 
(0.5 /zM) alone induced both apoptotic and necrotic cells. 
Larger cells, which included propidium iodide, were designated 
as necrotic and were evident as early as 2 h after treatment (data 
not shown), while apoptotic ells were not observed in signifi- 
cant numbers until 4 h. These results indicated that the necrotic 
cells induced by staurosporine did not arise from secondary 
necrosis of apoptotic cells. Cotreatment with TLCK poten- 
tiated the induction of apoptotic cells (Table 1) and also re- 
duced the percentage of propidium iodide including cells in- 
duced by staurosporine. 
To investigate the involvement of ICE like-protease activity 
in the induction of apoptosis, cells were incubated for 1 h with 
Z-VAD.FMK,  an inhibitor of ICE-like proteases, prior to ex- 
posure to the apoptotic stimuli. Z -VAD.FMK (50/zM) caused 
an almost otal inhibit ion of apoptosis induced by all the stimuli 
either alone or in the presence of TLCK (Table 1). However, 
Z -VAD.FMK had little or no effect on STS-induced necrotic 
cell death suggesting that the ICE-like protease activity was not 
involved in necrosis. Our data supported a significant role for 
an ICE-like protease as a common mediator of the induction 
of apoptosis by diverse stimuli. 
3.2. Z- VAD. FMK inhibits the formation of large kilobasepair 
fragments of DNA induced by diverse stimuli 
In order to ascertain at what stage of the apoptotic process 
Z -VAD.FMK was exerting its inhibitory effect, THP.1 cells 
Table 1 
Z-VAD.FMK inhibits apoptosis induced by various stimuli 
Stimulis TLCK Z-VAD.FMK 
- + 
Control - 2.3 ~ + 1.7 2.1 _+ 1.5 
Control + 3.2 _+ 0.8 2.3 + 2.0 
CHX - 15.5 + 0.5 5.4 + 2.0 
CHX + 63.6 + 3.7 1.5 _+ 0.4 
ETOP - 32.0 + 4.3 2.8 + 1.20 
ETOP + 7.5 _+ 2.9 1.8 8 
STS - 18.1 + 4.0 c 3.2 _+ 2.4 
STS + 47.2 + 11.7 3.3-+0.4 
THG - 9.6 + 1.3 4.0 + 1.9 
THG + 59.3 _+ 8.2 1.9 _+ 0.7 
THE1 cells were incubated for 1 h either alone or in the presence of 
Z-VAD.FMK (50pM). They were then further incubated for 4 h in the 
presence or absence of TLCK (100/zM) either alone or with cyclo- 
heximide (25 pM) (CHX), etoposide (25 ,uM) (ETOP), staurosporine 
(0.5 pM) (STS) or thapsigargin (100 nM) (THG). 
The percentage of apoptotic ells was assessed by flow cytometry. 
Results are expressed as mean + S.E.M. of at least 3 separate xperi- 
ments. 
bAs TLCK and Z-VAD.FMK alone inhibited etoposide-induced apop- 
tosis, the combination was studied in one experiment only. 
c With staurosporine alone, necrotic ells were also induced. 
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Fig. 1. Separation of apoptotic and normal cells by flow cytometry. THP.1 cells were incubated for 4 h with cycloheximide (CHX) (25 pM) in the 
presence of TLCK (100,uM), stained with Hoechst 33342 and propidium iodide and then sorted by flow cytometry. Non-viable cells, which included 
propidium iodide, were gated out and the remaining cells were displayed as a cytogram of blue fluorescence versus light forward light scatter (FSC). 
Two populations were sorted and examined by fluorescence microscopy• Cells exhibiting low blue fluorescence (R1) with morphology similar to 
untreated cells and those exhibiting high blue fluorescence (R2) with distinctive apoptotic morphology. 
were exposed to diverse stimuli in the presence or absence of 
TLCK and Z-VAD.FMK and cleavage of DNA to large kilo- 
basepair fragments was examined. Little or no DNA cleavage 
was observed in control cells and cells incubated with TLCK 
or Z -VAD.FMK alone (Fig. 2). However, substantial cleavage 
of DNA to large ki lobasepair fragments was observed in cells 
exposed for 4 h to staurosporine, thapsigargin, cycloheximide 
and etoposide (Fig. 2). Coincubat ion ofTHP.  1 cells for 4 h with 
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Fig. 2. Z-VAD.FMK inhibits formation of large kilobase-pair fragments of DNA induced by apoptotic stimuli. THE 1 cells were incubated either 
alone or with Z-VAD.FMK (50/IM) for 1 h and then further incubated for 4 h either with the apoptotic stimulus alone or in the presence ofTLCK 
(100/tM). Cells were incubated with staurosporine (0.5/~M) (STS), thapsigargin (100 nM) (THG), cycloheximide (25/~M) (CHX) or etoposide (25 
pM) (ETOP). They were then analysed for formation of large kilobasepair fragments by field inversion gel electrophoresis. The arrow on the left 
side of the figure indicates the 48.5 kilobase-pair standard for the control, staurosporine and thapsigargin experiments. The arrow on the right is 
the same standard for the experiments with cycloheximide and etoposide. 
thapsigargin or cycloheximide in the presence of TLCK, re- 
sulted in increased formation of large kilobasepair f agments, 
particularly of 30-50 kbp (Fig. 2). This increase in DNA cleav- 
age correlated well with the increased apoptosis of both these 
agents by TLCK (Table 1). TLCK inhibited etoposide-induced 
formation of large fragments of DNA (Fig. 2) also in agreement 
with its inhibition of etoposide-induced apoptosis (Table 1). 
Z-VAD.FMK almost completely inhibited the formation of 
large kilobasepair induced by all four stimuli (Fig. 2). Similarly 
Z-VAD.FMK almost completely inhibited the enhanced for- 
mation of large kilobasepair fragments induced by thapsigargin 
or cycloheximide in the presence of TLCK (Fig. 2), in good 
agreement with its ability to inhibit apoptosis induced by these 
treatments (Table 1). These stimuli also induced internucleo- 
somal cleavage of DNA, which was inhibited by Z-VAD. FM K 
(data not shown). These results suggested that an ICE-like 
protease(s) acts at a stage prior to the formation of large kilo- 
basepair fragments of DNA. 
In order to test if ICE or an ICE homologue(s) was involved 
as a common mediator of apoptosis, cells were pretreated for 
1 h with two other more specific inhibitors of ICE and then 
exposed to the apoptotic stimuli. YVAD.CHO (10-100 ,uM) 
did not inhibit the induction of apoptosis induced by thapsi- 
gargin, cycloheximide, toposide or staurosporine asassessed 
by either flow cytometry or agarose gel electrophoresis (data 
not shown). YVAD.CMK (100/IM) had a differential effect, 
partially inhibiting DNA fragmentation i duced by thapsi- 
gargin, cycloheximide, toposide and staurosporine but did not 
inhibit the formation of apoptosis assessed by flow cytometry 
(data not shown). 
3.3. PARP proteolysis accompanies apoptosis and was inhibited 
by Z -VAD.FMK 
Proteolysis of intact PARP (116 kDa) to an 85 kDa fragment 
has been described as an early marker of apoptosis in a number 
of different cellular systems [24]. In order to obtain some insight 
on the possible involvement of proteolysis in the induction of 
apoptosis in THE 1 cells, we examined whether proteolysis of 
PARP accompanied apoptosis and whether it was sensitive to 
an inhibitor of ICE-like proteases. In control cells or cells 
treated with either Z-VAD.FMK or TLCK for 4 h, there was 
little or no degradation of intact PARP (116 kDa) (Fig. 3, lanes 
1, 2 and 5, respectively). A small amount of PARP proteolysis 
was observed in cells exposed for 4 h to cycloheximide, stauro- 
sporine or thapsigargin (data not shown) commensurate with 
their induction of apoptosis. Co-treatment of ceils with TLCK 
followed by cycloheximide or thapsigargin, which resulted in 
a potentiation f apoptosis (Table 1), resulted in an almost otal 
loss of intact PARP (116 kDa) accompanied by the appearance 
of a number of proteolytic products, particularly an 85 kDa 
fragment (Fig. 3, lanes 3 and 6). Pretreatment for 1 h with 
Z-VAD.FMK (50 ~tM), which totally inhibited the inducton of 
apoptosis (Table 1) prevented the loss of intact PARP and the 
appearance of the 85 kDa fragment (Fig. 3, lanes 4 and 7). 
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Fig. 3. Z-VAD.FMK inhibits PARP proteolysis nduced by apoptotic 
stimuli. THP.1 cells were incubated for 4 h alone (lane 1). Cells were 
also incubated for 4 h with TLCK (100/.tM) either alone (lane 5) or in 
the presence of cycloheximide (25/~M) (lane 3) or thapsigargin (100 
nM) (lane 6). Cells were preincubated for 1 h with Z-VAD.FMK (50 
~tM) followed by an incubation for 4 h either alone (lane 2) or with 
TLCK (100/.tM) and cycloheximide (25/gM) (lane 4) or TLCK (100 
~M) and thapsigargin (100 nM) (lane 7). Proteolysis of PARP was 
induced by the apoptotic stimuli and inhibited by Z-VAD.FMK. The 
arrows indicate intact PARP (116 kDa) and the 85 kDa fragment. 
Etoposide alone induced proteolysis of intact PARP which was 
almost completely inhibited by either TLCK or Z-VAD.FMK 
(data not shown). These data demonstrate hat proteolysis of 
PARP correlated with the induction of apoptosis in THE1 
cells, i.e. treatments which enhanced apoptosis resulted in a 
greater proteolysis whereas treatments which inhibited apopto- 
sis inhibited proteolysis. The inhibition of proteolysis of PARP 
by Z-VAD.FMK provided indirect evidence that Z- 
VAD.FMK was inhibiting a protease. 
4. Discussion 
Apoptosis was induced in THE 1 cells by a number of stimuli 
acting by diverse mechanisms (Table 1). This was consistent 
with the proposal that such stimuli activate private signalling 
pathways which ultimately converge on a common apoptotic 
pathway(s) characterized by a series of common biochemical 
and morphological changes. The induction of apoptosis by all 
these stimuli except etoposide was enhanced by TLCK and 
these effects were totally abrogated by Z-VAD.FMK. Z-VAD- 
FMK has also been shown to inhibit Fas-mediated apoptosis 
in T lymphocytes [33]. Our data strongly support he involve- 
ment in THE 1 cells of a Z-VAD.FMK inhibitable target, most 
probably an ICE-like protease, within a common apoptotic 
pathway (Fig, 4). This target acts at an early stage of the 
apoptotic process as Z-VAD.FMK inhibited the morphological 
and biochemical changes of apoptosis including formation of 
large kilobasepair f agments of DNA (Fig. 2) and internucleo- 
somal cleavage (data not shown) as well as the induction 
of apoptotic cells (Table 1). A similar inhibition of dexa- 
methasone-, etoposide- and thapsigargin-induced apoptosis 
was observed in thymocyte apoptosis. Our data demonstrating 
that Z-VAD.FMK but not YVAD.CHO and YVAD.CMK 
inhibited apoptosis may have been due to a differential cell 
permeability of the inhibitors or to the possible involvement of
an ICE homologue(s) other than ICE as a common mediator 
of apoptosis. This is based on the observations of the absolute 
requirement of peptide substrates of ICE for an aspartate inthe 
P1 position and also that they must contain at least four amino 
acids on the N-terminal side of the cleavage site, as removal of 
the amino acid in the P4 position results in a very marked loss 
of activity [25]. Thus Z-VAD.FMK, with an aspartate in the P1 
position but no amino acid in the P4 position, should inhibit 
ICE-like proteases but not ICE per se. Whilst our data suggests 
the involvement in the induction of apoptosis of an ICE hom- 
ologue rather than ICE itself, we cannot exclude apossible role 
for both ICE and an ICE homologue assuming that both activ- 
ities are blocked by Z-VAD.FMK. 
Proteolysis of PARP (116 kDa) with the concomittant gener- 
ation of an 85 kDa fragment has been proposed as a marker 
of early apoptosis [24]. In a cell-free model of apoptosis, this 
cleavage was carried out by an ICE-like protease (priCE) [34]. 
We therefore used PARP degradation asa marker for ICE-like 
proteolysis. Our results demonstrated that PARP proteolysis 
accompanied apoptosis in THE 1 cells (Fig. 3). This proteolysis 
was markedly enhanced by apoptotic stimuli n the presence of 
TLCK and this enhanced proteolysis was completely inhibited 
by Z-VAD.FMK (Fig. 3). This data is consistent with the in- 
volvement of an ICE-like protease in PARP proteolysis. How- 
ever the significance of PARP proteolysis in apoptosis is un- 
clear as a PARP knockout mouse developed normally [35]. This 
suggested that apoptosis probably does not have an absolute 
requirement for proteolysis of PARP but rather that it may be 
a consequence of cell death. 
TLCK caused a marked enhancement of apoptosis induced 
by three of the stimuli used to induce apoptosis but inhibited 
apoptosis induced by etoposide, a DNA topoisomerase II in- 
hibitor (Table 1). The reason why TLCK inhibits apoptosis 
induced by etoposide is unclear but may be related to an early 
step in the damage induced by etoposide. Similarly in HL-60 
cells, TLCK inhibited apoptosis induced by camptothecin, a 
DNA topoisomerase I inhibitor, but potentiated that induced 
by cycloheximide [36]. The present results were in marked con- 
trast to our earlier study with thymocytes when apoptosis in- 
duced by diverse stimuli was inhibited by TLCK [22]. These 
contrasting results uggest that the TLCK target(s) is not part 
of the effector mechanism but rather that it has an important 
function either positively or negatively regulating apoptosis 
depending on the cell type. The same signal may have opposite 
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Fig. 4. Model of apoptosis in THE1 cells. Diverse stimuli ncluding 
thapsigargin (THG), staurosporine (STS), etoposide (ETOP) and cyclo- 
heximide (CHX) act on inidvidual private signalling pathways in nor- 
mal THE 1 cells. Diverse agents induce aseries of common biochemical 
and morphological changes characteristic of apoptotic ells culminat- 
ing in the cleavage of DNA to large kilobasepair (kbp) (200 300 and 
30-50 kbp) and nucleosomal fragments. Z-VAD.FMK, an ICE-like 
protease inhibitor, inhibits all the biochemical nd morphological fea- 
tures of apoptosis nduced by all these stimuli. 
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effects on different cell types and even on the same cell type at 
different stages of development [6,7]. 
In summary, our data support a model demonstrating a role 
in THP. I cells for an ICE-like protease acting as a common 
mediator of apoptosis induced by various stimuli (Fig. 4). Our 
data lend further support to a common cell death program 
conserved between species. 
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